AtriCure, Inc. (ATRC) vs LeMaitre Vascular, Inc. (LMAT)
- AtriCure, Inc. ATRC 56.09 −2.92%
- LeMaitre Vascular, Inc. LMAT 80.82 −2.81%
AtriCure, Inc. and LeMaitre Vascular, Inc. are both Medical Instruments & Supplies companies. AtriCure, Inc. is the larger, with a market value of $2.9B against $1.9B — 1.5× the size. LeMaitre Vascular, Inc. trades at the lower P/E: 27.9× against 259×. AtriCure, Inc. grew revenue faster over the last twelve months: 13.9% against 11.9%. LeMaitre Vascular, Inc. has the higher net margin (25.0% vs 1.85%) and the higher return on invested capital (22.7% vs 1.92%). Across the 22 metrics below, LeMaitre Vascular, Inc. leads on 14 and AtriCure, Inc. on 8.
Valuation
Profitability
| Metric | ATRC | LMAT | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 76.30% | 72.90% | 54.29% |
| Operating margin | 2.26% | 29.46% | 1.07% |
| Net margin | 1.85% | 25.02% | (1.61%) |
| Free cash flow margin | 9.32% | 28.13% | 1.08% |
| Return on equity | 2.15% | 16.77% | (1.32%) |
| Return on assets | 1.64% | 10.78% | 0.00% |
| Return on invested capital | 1.92% | 22.67% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack